West Pharmaceutical Services Inc. Stock
West Pharmaceutical Services Inc. gained 0.940% compared to yesterday.
West Pharmaceutical Services Inc. is currently one of the favorites of our community with 6 Buy predictions and no Sell predictions.
With a target price of 369 € there is a positive potential of 21.42% for West Pharmaceutical Services Inc. compared to the current price of 303.9 €.
Pros and Cons of West Pharmaceutical Services Inc. in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of West Pharmaceutical Services Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
West Pharmaceutical Services Inc. | 0.940% | -0.556% | -11.554% | -4.223% | -5.327% | 11.156% | - |
Neogen Corp. | 3.360% | 1.653% | 8.850% | -27.647% | -32.787% | -66.531% | -50.597% |
Bio-Rad Labs Inc. A | -1.520% | -1.624% | 0.077% | -25.058% | -11.274% | -45.502% | - |
Merit Medical Systems | -1.340% | -2.000% | 4.255% | -6.369% | 8.088% | 47.590% | 57.270% |
Comments
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at KeyCorp from $440.00 to $470.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $536.00 price target on the stock, up previously from $323.00.
Show more
Ratings data for WST provided by MarketBeat
West Pharmaceutical Services, Inc. (NYSE: WST) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Show more
Ratings data for WST provided by MarketBeat